- Home
- HLVX vs ICAD Comparison
HLVX vs ICAD Comparison
Compare HLVX & ICAD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HLVX
- ICAD
- Stock Information
- Founded
- HLVX 2020
- ICAD 1984
- Country
- HLVX United States
- ICAD United States
- Employees
- HLVX N/A
- ICAD N/A
- Industry
- HLVX Biotechnology: Pharmaceutical Preparations
- ICAD Medical/Dental Instruments
- Sector
- HLVX Health Care
- ICAD Health Care
- Exchange
- HLVX Nasdaq
- ICAD Nasdaq
- Market Cap
- HLVX 83.7M
- ICAD 87.5M
- IPO Year
- HLVX 2022
- ICAD 1986
- Fundamental
- Price
- HLVX $1.39
- ICAD $1.98
- Analyst Decision
- HLVX Hold
- ICAD
- Analyst Count
- HLVX 5
- ICAD 0
- Target Price
- HLVX $2.33
- ICAD N/A
- AVG Volume (30 Days)
- HLVX 144.6K
- ICAD 274.2K
- Earning Date
- HLVX 03-28-2025
- ICAD 03-19-2025
- Dividend Yield
- HLVX N/A
- ICAD N/A
- EPS Growth
- HLVX N/A
- ICAD N/A
- EPS
- HLVX N/A
- ICAD N/A
- Revenue
- HLVX N/A
- ICAD $19,608,000.00
- Revenue This Year
- HLVX N/A
- ICAD $2.39
- Revenue Next Year
- HLVX N/A
- ICAD $13.71
- P/E Ratio
- HLVX N/A
- ICAD N/A
- Revenue Growth
- HLVX N/A
- ICAD 13.22
- 52 Week Low
- HLVX $1.37
- ICAD $1.18
- 52 Week High
- HLVX $16.31
- ICAD $3.78
- Technical
- Relative Strength Index (RSI)
- HLVX 17.95
- ICAD 36.58
- Support Level
- HLVX $1.70
- ICAD $2.05
- Resistance Level
- HLVX $1.71
- ICAD $2.48
- Average True Range (ATR)
- HLVX 0.08
- ICAD 0.16
- MACD
- HLVX -0.03
- ICAD -0.01
- Stochastic Oscillator
- HLVX 3.41
- ICAD 5.66
About HLVX HilleVax Inc.
HilleVax Inc is a clinical-stage biopharmaceutical company. The company is focused on developing and commercializing novel vaccines. The firm's initial program, HIL-214, is a virus-like particle (VLP) based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis (AGE) caused by norovirus infection.
About ICAD iCAD Inc.
icad Inc is a medical technology company providing cancer detection and therapy solutions. The Company operates in one segment: Detection. The Detection segment include advanced image analysis and workflow solutions that enable healthcare professionals to serve patients by identifying pathologies, comprehensive range of high-performance, Artificial Intelligence and Computer-Aided Detection (CAD) systems and workflow solutions for 2D and 3D mammography, Magnetic Resonance Imaging and Computed Tomography. The company geographically operates in France, Belgium, Italy, Germany, Switzerland and All other.